Bank of Hawaii trimmed its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 19.4% in the fourth quarter, Holdings Channel reports. The fund owned 14,817 shares of the medical research company’s stock after selling 3,577 shares during the period. Bank of Hawaii’s holdings in Thermo Fisher Scientific were worth $2,813,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also made changes to their positions in the company. Americafirst Capital Management LLC bought a new stake in shares of Thermo Fisher Scientific in the 3rd quarter worth approximately $876,000. Rockland Trust Co. increased its stake in shares of Thermo Fisher Scientific by 7.3% in the fourth quarter. Rockland Trust Co. now owns 62,332 shares of the medical research company’s stock worth $11,836,000 after buying an additional 4,221 shares during the period. San Francisco Sentry Investment Group CA purchased a new position in shares of Thermo Fisher Scientific in the second quarter worth $1,451,000. Huntington National Bank increased its stake in shares of Thermo Fisher Scientific by 2.4% in the third quarter. Huntington National Bank now owns 195,348 shares of the medical research company’s stock worth $36,959,000 after buying an additional 4,655 shares during the period. Finally, Toronto Dominion Bank increased its stake in shares of Thermo Fisher Scientific by 25.4% in the second quarter. Toronto Dominion Bank now owns 134,277 shares of the medical research company’s stock worth $23,424,000 after buying an additional 27,178 shares during the period. Hedge funds and other institutional investors own 86.54% of the company’s stock.
Several research analysts recently commented on the stock. Morgan Stanley lifted their target price on shares of Thermo Fisher Scientific from $223.00 to $227.00 and gave the stock an “overweight” rating in a research note on Thursday, February 1st. Barclays lifted their target price on shares of Thermo Fisher Scientific from $225.00 to $245.00 and gave the stock an “overweight” rating in a research note on Thursday, February 1st. Leerink Swann reaffirmed an “outperform” rating and issued a $239.00 target price (up from $200.00) on shares of Thermo Fisher Scientific in a research note on Thursday, February 1st. They noted that the move was a valuation call. ValuEngine raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd. Finally, Bank of America lifted their target price on shares of Thermo Fisher Scientific from $235.00 to $250.00 and gave the stock a “buy” rating in a research note on Thursday, February 1st. Two equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. Thermo Fisher Scientific currently has an average rating of “Buy” and an average target price of $220.50.
In other news, Director William G. Parrett sold 1,000 shares of the company’s stock in a transaction dated Thursday, February 15th. The shares were sold at an average price of $209.80, for a total value of $209,800.00. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Marc N. Casper sold 50,000 shares of the company’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $191.74, for a total transaction of $9,587,000.00. Following the completion of the sale, the chief executive officer now directly owns 302,577 shares in the company, valued at $58,016,113.98. The disclosure for this sale can be found here. Insiders sold a total of 95,327 shares of company stock worth $19,470,342 over the last ninety days. Insiders own 0.49% of the company’s stock.
Thermo Fisher Scientific Inc. (NYSE TMO) opened at $209.13 on Friday. The company has a current ratio of 1.35, a quick ratio of 0.92 and a debt-to-equity ratio of 0.74. The stock has a market cap of $83,860.00, a price-to-earnings ratio of 34.28, a price-to-earnings-growth ratio of 1.52 and a beta of 1.11. Thermo Fisher Scientific Inc. has a 1 year low of $151.74 and a 1 year high of $226.44.
Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Wednesday, January 31st. The medical research company reported $2.79 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.66 by $0.13. The firm had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $5.72 billion. Thermo Fisher Scientific had a net margin of 10.64% and a return on equity of 16.01%. The company’s revenue was up 22.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.41 EPS. equities research analysts predict that Thermo Fisher Scientific Inc. will post 10.81 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, April 16th. Stockholders of record on Thursday, March 15th will be given a $0.17 dividend. The ex-dividend date is Wednesday, March 14th. This is an increase from Thermo Fisher Scientific’s previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.33%. Thermo Fisher Scientific’s dividend payout ratio is currently 9.84%.
WARNING: “Bank of Hawaii Sells 3,577 Shares of Thermo Fisher Scientific Inc. (TMO)” was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this news story on another website, it was illegally stolen and reposted in violation of US and international copyright laws. The legal version of this news story can be accessed at https://www.dispatchtribunal.com/2018/02/23/bank-of-hawaii-sells-3577-shares-of-thermo-fisher-scientific-inc-tmo.html.
Thermo Fisher Scientific Profile
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.